HOME >> MEDICINE >> NEWS
Express Scripts 1999 drug trend report: Seniors hit hardest by record 17.4-Percent prescription drug spending increase

e average seven prescriptions per year consumed by those younger than 65. The per-member-per-year cost difference between the two age groups was even greater: $1,185 vs. $267.

Also reported were findings, some of the first using pharmacy claims data, on how seniors responded to caps placed on their pharmacy benefit. Researchers found that, compared to seniors who did not exceed their prescription caps, seniors who had exceeded their plan's spending cap were significantly more likely to have stopped taking medicines across the 11 therapy categories most utilized by seniors. These categories were predominantly represented by therapies used to treat chronic conditions such as cardiovascular disease, diabetes, and hypothyroidism.

The risk of discontinuation was greatest among therapy categories used to treat cardiovascular disease, such as calcium channel blockers, antihyperlipidemics, and beta-blockers. Additionally, researchers found that, for a majority of therapy classes, less than half of those who stopped therapy resumed therapy once the benefit became available again the following year.

"Because seniors depend so heavily on prescription drugs, bear some of the highest costs and have such complex utilization patterns, providing them with prescription drug coverage is one of the biggest challenges currently on the pharmacy landscape," said Barrett Toan, chief executive officer of Express Scripts.

"Express Scripts believes there should be a prescription benefit for seniors, either through Medicare or some other initiative, but it should be understandable and simple to administer, and it should encourage cost-effective behavior by the beneficiary," he added.

Release of the Express Scripts 1999 Drug Trend Report and the senior prescription utilization study findings came during the company's annual Outcomes Conference, where more than 700 employer, managed care, medical and pharmacy benefit participants are reviewing the latest developme
'"/>

Contact: Ryan Soderstrom
rsoderst@express-scripts.com
612-837-5160
Kupper Parker Communications
26-Jun-2000


Page: 1 2 3 4

Related medicine news :

1. New evidence about positive three-tier co-pay performance presented at Express Scripts 2000 Outcomes Conference
2. Tracking trends in cochlear implant complications using a federal database
3. Changing trends in herbal supplement use
4. New figures highlight trends in drug and alcohol misuse
5. Study of trends in celiac disease
6. Different approaches required for monitoring suicide trends
7. Screening for depression at primary level could be next trend in healthcare
8. Study identifies trends in self-referred imaging
9. First quarter prescription drug spending: Generic drugs slow upward trend
10. Why trends in stroke death in 20th century appeared different to death from heart disease
11. CDC reports latest syphilis trends in United States

Post Your Comments:
(Date:7/21/2014)... PowerObjects, a professional services firm ... add-ons for Microsoft Dynamics CRM, has joined the ... group of the most strategic Microsoft Dynamics partners ... rank them in the highest echelon of the ... the Microsoft Dynamics Inner Circle have performed to ...
(Date:7/21/2014)... have a clot in their legs and are ... medication or undergo a minimally-invasive catheter-based clot removal ... difference in death rates between the two treatments, ... catheter procedure, according to a study by Temple ... a review of more than 90,000 cases nationwide., ...
(Date:7/21/2014)... The "viral reservoir" in which HIV can lie dormant ... earlier than previously thought, new animal research indicates. ... eradicate the AIDS-causing virus, said Harvard researchers working with ... presence of the viral reservoir remains the most significant ... HIV, known as HIV-1. "We found that the ...
(Date:7/21/2014)... (PRWEB) July 21, 2014 Western ... “Great College to Work For” by the Chronicle ... and also made the Honor Roll for the ... categories: Collaborative Governance, Compensation and Benefits, Confidence in ... Respect & Appreciation. , “Western University of Health ...
(Date:7/21/2014)... A new study suggests that potential help in lowering ... refrigerator. The study found that regular intake of ... supplements, may help ease the condition. Researchers looked ... probiotics and blood pressure. The studies involved a total ... pressure. People who consumed probiotics had an average ...
Breaking Medicine News(10 mins):Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:Temple study compares deep vein thrombosis therapies 2Health News:Temple study compares deep vein thrombosis therapies 3Health News:Temple study compares deep vein thrombosis therapies 4Health News:Animal Experiments Shed Light on HIV's Ability to Hide 2Health News:Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll 2Health News:Could Probiotics Help Tame High Blood Pressure? 2
(Date:7/21/2014)... , July 21, 2014 Integrity Applications, ... of the GlucoTrack ® model DF-F noninvasive ... has entered, through its wholly-owned subsidiary, Integrity Applications ... the manufacturing arm of Acer Inc.  Pursuant to ... service (on a non-exclusive basis) the GlucoTrack Model ...
(Date:7/21/2014)... Calif. , July 21, 2014   ... a biopharmaceutical company leading the discovery and development ... the U.S. Food & Drug Administration (FDA) has ... stranded, chemically modified oligonucleotide that binds to and ... therapeutic for the treatment of Alport syndrome, a ...
(Date:7/21/2014)... -- An International Trade Commission (ITC) ruling issued Friday held ... Taiwanese device manufacturer APEX continues to infringe ResMed patents ... is the innovation leader and pioneer in designing and ... "Our research and development teams are constantly ... comfort, performance and efficacy," said David Pendarvis , ...
Breaking Medicine Technology:Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 2Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2
Cached News: